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Background: Prosthesis-patient mismatch (PPM) remains a concern after valve replacement. This study sought to evaluate the hemodynamic 
performance of a new low profile stented pericardial tissue bioprosthesis (Trifecta, St. Jude Medical, St. Paul, MN) for aortic valve replacement; 
compared to a widely used stented bioprosthetic pericardial valve (Epic, St. Jude Medical, St. Paul. MN).
methods: From January 2010 to May 2012, 125 patients (mean age 73.6 ± 11.0 years) had aortic valve replacement for stenosis (93.5%) 
or regurgitation (6.5%). Prosthetic valve types used were Trifecta (n=75, 60.5%) and Epic (n=49, 39.5%). Intraoperative 3D and Doppler 
transesophageal echocardiography (TEE) was used to evaluate hemodynamic variables pre- and post- replacement as well as pre-discharge.
results: Baseline demographics were similar in both groups. Post-operative mean pressure gradient (MG) measurements demonstrate significantly 
improved hemodynamic performance in favor of the Trifecta valve (Fig. 1). Compared to the Trifecta, postoperative MG demonstrate a shift upwards 
in the Epic hemodynamic curve for any given valve effective orifice area (EOA) indicating higher relative obstructions to flow with smaller valve sizes. 
Severe PPM (defined as (EOAI ≤ 0.65) was more frequent in the Epic than Trifecta group (28% vs. 6%, p=0.0011).
conclusions: The hemodynamic performance of the Trifecta valve is superior to the Epic valve across all prosthesis sizes and resulted in 
substantially lower rates of severe PPM.
